Study
High-Dose CBD Does Not Improve Knee Osteoarthritis Pain in Seniors
Adding high-dose CBD to paracetamol showed no additional pain relief for knee osteoarthritis sufferers.
Summary
In plain language
Researchers investigated whether taking high-dose cannabidiol (CBD) along with paracetamol could help reduce knee pain from osteoarthritis. The study involved 86 participants, most of whom were seniors, who took either CBD or a placebo for 8 weeks. Results showed that both groups experienced similar levels of pain relief, indicating that CBD did not provide additional benefits. Moreover, those taking CBD reported more side effects, particularly related to liver enzymes. This study suggests that CBD may not be a helpful supplement for managing osteoarthritis pain in the knee. Seniors considering CBD should discuss its benefits and risks with their healthcare providers.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study aimed to explore if adding high-dose CBD to regular paracetamol treatment could ease knee osteoarthritis pain more effectively than a placebo. It was a randomized, double-blind trial involving 86 adults, mainly seniors, with chronic knee pain. Participants took either 600 mg of CBD or a placebo daily for 8 weeks.
Both groups showed similar pain reduction, with no significant difference between those taking CBD and those taking a placebo.
Participants using CBD experienced more side effects, particularly concerning liver enzyme levels.
The study concluded that high-dose CBD does not enhance pain relief when added to paracetamol for knee osteoarthritis.
Seniors should consult with their healthcare providers before adding CBD to their treatment plans, considering the lack of additional benefits and potential side effects.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
High-Dose CBD Does Not Improve Knee Osteoarthritis Pain in Seniors
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 27, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous design, including randomization, blinding, and allocation concealment. It was well-powered with pre-specified endpoints and transparent reporting. The absence of conflicts of interest and publication in a high-tier journal further supported its quality. However, the lack of replication evidence slightly reduced the overall score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized, double-blind, placebo-controlled trial evaluated the effect of high-dose oral CBD as an add-on to paracetamol in seniors with knee osteoarthritis. It found no significant analgesic benefit of CBD over placebo after 8 weeks.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Osteoarthritis of the Knee
Knee osteoarthritis is a degenerative joint condition where the protective cartilage in the knee gradually wears down over time. This leads to pain, stiffness, and reduced range of motion that can make everyday activities like walking, climbing stairs, or standing from a chair more challenging. It is one of the most common causes of disability among older adults.
Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease that primarily affects the cartilage, the smooth tissue that cushions the ends of bones in joints. As cartilage breaks down, bones may rub together, causing pain, stiffness, and loss of function. Osteoarthritis is particularly common among older adults, affecting millions of people worldwide.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.